Fig. 6.
Fig. 6. STAT activation in resting PBMCs exposed in vitro to HIV-1. EMSA using WCEs (8 μg) obtained from resting PBMCs, NA-PBMCs, and M▹ exposed for 7 days to HIV-1IIIB/LAI and HIV-1BaL strains (0.1 moi) and a mixture of PRE and UCR radiolabeled oligonucleotides. After a single round of purification, CD4+-depleted PBMCs of patients no. 15 and 16 contained 3% and 1% CD4+ cells, respectively, whereas CD8+-depleted PBMCs contained 0.3% and 1% CD8+ cells, respectively.

STAT activation in resting PBMCs exposed in vitro to HIV-1. EMSA using WCEs (8 μg) obtained from resting PBMCs, NA-PBMCs, and M▹ exposed for 7 days to HIV-1IIIB/LAI and HIV-1BaL strains (0.1 moi) and a mixture of PRE and UCR radiolabeled oligonucleotides. After a single round of purification, CD4+-depleted PBMCs of patients no. 15 and 16 contained 3% and 1% CD4+ cells, respectively, whereas CD8+-depleted PBMCs contained 0.3% and 1% CD8+ cells, respectively.

Close Modal

or Create an Account

Close Modal
Close Modal